These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 35597066)
1. Effıcacy of cıtalopram on stroke recurrence: A randomızed clınıcal trıal. Ece Çetin F; Kumral E; Saffet Gönül A; Nezih Özdemir H; Orman M J Clin Neurosci; 2022 Jul; 101():168-174. PubMed ID: 35597066 [TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Lenox-Smith AJ; Jiang Q Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525 [TBL] [Abstract][Full Text] [Related]
3. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC; JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833 [TBL] [Abstract][Full Text] [Related]
4. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. Robinson RG; Jorge RE; Moser DJ; Acion L; Solodkin A; Small SL; Fonzetti P; Hegel M; Arndt S JAMA; 2008 May; 299(20):2391-400. PubMed ID: 18505948 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial. Savadi Oskouie D; Sharifipour E; Sadeghi Bazargani H; Hashemilar M; Nikanfar M; Ghazanfari Amlashi S; Abbaszade Z; Sadeghihokmabadi E; Rikhtegar R; Golzari SEJ Neurorehabil Neural Repair; 2017 Jul; 31(7):638-647. PubMed ID: 28454498 [TBL] [Abstract][Full Text] [Related]
6. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645 [TBL] [Abstract][Full Text] [Related]
7. TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke. Kraglund KL; Mortensen JK; Grove EL; Johnsen SP; Andersen G Int J Stroke; 2015 Aug; 10(6):985-7. PubMed ID: 25854537 [TBL] [Abstract][Full Text] [Related]
8. Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS). Kraglund KL; Mortensen JK; Damsbo AG; Modrau B; Simonsen SA; Iversen HK; Madsen M; Grove EL; Johnsen SP; Andersen G Stroke; 2018 Nov; 49(11):2568-2576. PubMed ID: 30355209 [TBL] [Abstract][Full Text] [Related]
9. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population. Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753 [TBL] [Abstract][Full Text] [Related]
10. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Burke WJ; Gergel I; Bose A J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207 [TBL] [Abstract][Full Text] [Related]
11. Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression. Bschor T; Uhr M; Baethge C; Lewitzka U; Ising M; Erbe S; Winkelmann P; Ritter D J Clin Psychopharmacol; 2013 Feb; 33(1):38-44. PubMed ID: 23277245 [TBL] [Abstract][Full Text] [Related]
12. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058 [TBL] [Abstract][Full Text] [Related]
13. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Klysner R; Bent-Hansen J; Hansen HL; Lunde M; Pleidrup E; Poulsen DL; Andersen M; Petersen HE Br J Psychiatry; 2002 Jul; 181():29-35. PubMed ID: 12091260 [TBL] [Abstract][Full Text] [Related]
15. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Quante A; Zeugmann S; Luborzewski A; Schommer N; Langosch J; Born C; Anghelescu I; Wolf J Hum Psychopharmacol; 2010 Mar; 25(2):126-32. PubMed ID: 20196183 [TBL] [Abstract][Full Text] [Related]
16. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. Feighner JP; Overø K J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628 [TBL] [Abstract][Full Text] [Related]
17. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation. Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812 [TBL] [Abstract][Full Text] [Related]
18. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Andersen G; Vestergaard K; Lauritzen L Stroke; 1994 Jun; 25(6):1099-104. PubMed ID: 8202964 [TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Stahl SM Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227 [TBL] [Abstract][Full Text] [Related]
20. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Bent-Hansen J; Lunde M; Klysner R; Andersen M; Tanghøj P; Solstad K; Bech P Pharmacopsychiatry; 2003 Nov; 36(6):313-6. PubMed ID: 14663657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]